Author information:
(1)Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee.
(2)Division of Rheumatology and Immunology, Vanderbilt University, Nashville, 
Tennessee.
(3)Department of Biological Chemistry and Molecular Pharmacology, Harvard 
Medical School, Boston, Massachusetts. Dana Farber Cancer Institute, Harvard 
Medical School, Boston, Massachusetts.
(4)Department of Pathology, Microbiology, and Immunology, Vanderbilt University, 
Nashville, Tennessee.
(5)Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. 
Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.
(6)Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.
(7)Vanderbilt University Institute of Imaging Science, Vanderbilt University, 
Nashville, Tennessee.
(8)Department of Pathology, Microbiology, and Immunology, Vanderbilt University, 
Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University, 
Nashville, Tennessee.
(9)Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. 
Division of Rheumatology and Immunology, Vanderbilt University, Nashville, 
Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, 
Tennessee. Department of Cell and Developmental Biology, Vanderbilt University, 
Nashville, Tennessee. Veterans Affairs Medical Center, Tennessee Valley 
Healthcare System, Nashville, Tennessee. jin.chen@vanderbilt.edu.